Logo

Celera's Proteomics Cutbacks Topped Most-Read GenomeWeb Daily News Stories Last Week

Nov 05, 2007
NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Nov. 2.
 
1. Celera Cutting Back Proteomics Research Staff as Focus Shifts Downstream (from Oct. 29)
 
2. ABI Scuttles 1700 Array Platform for SOLiD Sequencer; Irks Partners, Customers (from Oct. 31)
 
3. Wash U Genomics Center to Spend $10M to Upgrade Bioinformatics Chops to Support Next-Gen Sequencers (from Oct. 30)
 
4. GSK Wins Injunction Against USPTO for Pending Patent Rule Changes (from Oct. 31)
 
5. Collins to Receive Medal of Freedom, Harwood Named Interim CEO of BioReliance, Myriad CFO Would Rather Be Racing, and More (from Nov. 2) 
 
Breaking News
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.